ES2100222T3 - Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas. - Google Patents
Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas.Info
- Publication number
- ES2100222T3 ES2100222T3 ES91810580T ES91810580T ES2100222T3 ES 2100222 T3 ES2100222 T3 ES 2100222T3 ES 91810580 T ES91810580 T ES 91810580T ES 91810580 T ES91810580 T ES 91810580T ES 2100222 T3 ES2100222 T3 ES 2100222T3
- Authority
- ES
- Spain
- Prior art keywords
- aminoalcansulfonico
- derivatives
- acid
- prevent
- pharmaceutical compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA PRESENTE INVENCION ESTA RELACIONADA CON UN COMPUESTO FARMACEUTICO PARA SU USO EN LA PREVENCION O TRATAMIENTO DE ENFERMEDADES DEL CORAZON EN UN MAMIFERO, QUE COMPRENDA AL MENOS UN DERIVADO DE ACIDO AMINOALCANOSULFONICO DE LA FORMULA (I): EN LA QUE X ES HIDROGENO O UN RESIDUO DE AMINOACIDO; Y ES HIDROGENO, UN GRUPO FENIL O UN GRUPO ALQUILO, QUE PUEDEN TENER UN GRUPO HIDROXIDO, AMINO, CARBOXIDO, FENIL O HIDROXIFENIL; O X E Y SE UNEN PARA FORMAR UN GRUPO TRIMETILENO O HIDROXITRIMETILENO; Y AL MENOS UNO DE X E Y ES DISTINTO DEL HIDROGENO; O SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2192575A JP3070687B2 (ja) | 1990-07-19 | 1990-07-19 | 心疾患治療剤 |
JP2223807A JP3068841B2 (ja) | 1990-08-23 | 1990-08-23 | アミノアルカンスルホン酸誘導体を有効成分として含有する心疾患治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2100222T3 true ES2100222T3 (es) | 1997-06-16 |
Family
ID=26507401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91810580T Expired - Lifetime ES2100222T3 (es) | 1990-07-19 | 1991-07-18 | Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas. |
Country Status (5)
Country | Link |
---|---|
US (1) | US5430052A (es) |
EP (1) | EP0467856B1 (es) |
AT (1) | ATE150301T1 (es) |
DE (1) | DE69125216T2 (es) |
ES (1) | ES2100222T3 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040208875A1 (en) * | 1995-03-15 | 2004-10-21 | Queen's University At Kingston | Method for treating amyloidosis |
WO1997014306A1 (en) * | 1995-10-17 | 1997-04-24 | Dovetail Technologies, Inc. | Low molecular weight cell, bone marrow and immune stimulants |
US20020022657A1 (en) * | 1998-02-11 | 2002-02-21 | Francine Gervais | Methods for modulating neuronal cell death |
AU2003217764A1 (en) * | 2002-03-01 | 2003-09-16 | Merck & Co., Inc. | Aminoalkylphosphonates and related compounds as edg receptor agonists |
US6774261B2 (en) * | 2002-08-29 | 2004-08-10 | Buffers & Biochemicals Corporation | High purity amino-organosulfonic acid zwitterionic compositions |
US7244764B2 (en) * | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
US7414076B2 (en) * | 2003-06-23 | 2008-08-19 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
NZ544687A (en) * | 2003-06-23 | 2009-06-26 | Bellus Health Int Ltd | Treatment of amyloid- and epileptogenesis-associated diseases |
US20070010573A1 (en) * | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
JP2008519822A (ja) * | 2004-11-12 | 2008-06-12 | ニューロケム (インターナショナル) リミテッド | アミロイド関連疾患を治療するための方法およびフッ素化組成物 |
EP1817305A2 (en) * | 2004-11-16 | 2007-08-15 | Neurochem (International) Limited | Compounds for the treatment of cns and amyloid associated diseases |
CA2592320C (en) * | 2004-12-22 | 2015-11-24 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
TW200716088A (en) * | 2005-04-15 | 2007-05-01 | Neurochem Int Ltd | Formulations and methods for treating amyloidosis |
US8372886B2 (en) * | 2005-12-22 | 2013-02-12 | Kiacta Sarl | Treatment of renal disorders, diabetic nephropathy and dyslipidemias |
US20070261933A1 (en) * | 2006-04-26 | 2007-11-15 | Scott C W | Conveyor roller assembly and conveyor roller insert |
PL3851447T3 (pl) | 2006-10-12 | 2024-03-04 | Bellus Health Inc. | Sposoby, związki, kompozycje i nośniki dostarczające kwas 3-amino-1-propanosulfonowy |
CA2673022A1 (en) * | 2006-12-22 | 2008-07-03 | Bellus Health (International) Limited | Methods, compounds, and compositions for treating metabolic disorders and diabetes |
JP5650642B2 (ja) * | 2008-08-01 | 2015-01-07 | バイオキシネス ファーマシューティカルズ, インコーポレイテッド | メチオニンアナログおよびそれらを使用する方法 |
FR2961392A1 (fr) * | 2010-06-17 | 2011-12-23 | Oreal | Utilisation de derives d'acide amine comme agent de traitement de la transpiration humaine ; nouveaux composes ; compositions les contenant |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3189M (fr) * | 1963-07-13 | 1965-03-15 | Pharmaco Biolog Soc | Médicament a base d'acide 2-amino-éthanesulfonique. |
NL6708311A (es) * | 1966-06-18 | 1967-12-19 | ||
JPS494210B1 (es) * | 1970-06-17 | 1974-01-31 | ||
CH665645A5 (fr) * | 1981-07-09 | 1988-05-31 | Michel Flork | Derives de dipeptides et leur procede de preparation. |
JPS5852253A (ja) * | 1981-09-21 | 1983-03-28 | Tanabe Seiyaku Co Ltd | Ρ−ヒドロキシフエニルグリシン・α−フエニルエタンスルホン酸塩及びその光学分割法 |
US5011983A (en) * | 1987-01-23 | 1991-04-30 | Minnesota Mining And Manufacturing Company | Preparation and reactions of omega-halosulfonyl perfluoroalkanesulfonates |
JPH0713052B2 (ja) * | 1987-02-27 | 1995-02-15 | 日本臓器製薬株式会社 | ジペプチド |
JPH07103100B2 (ja) * | 1987-02-27 | 1995-11-08 | 日本臓器製薬株式会社 | 新規ジペプチド |
JP2733511B2 (ja) * | 1988-10-22 | 1998-03-30 | 日本臓器製薬株式会社 | 新規アミノアルカン誘導体 |
JPH02243619A (ja) * | 1989-03-15 | 1990-09-27 | Green Cross Corp:The | 抗血小板凝集剤 |
JP2857461B2 (ja) * | 1990-03-28 | 1999-02-17 | 日本臓器製薬株式会社 | ジペプチド化合物 |
-
1991
- 1991-07-18 ES ES91810580T patent/ES2100222T3/es not_active Expired - Lifetime
- 1991-07-18 AT AT91810580T patent/ATE150301T1/de not_active IP Right Cessation
- 1991-07-18 DE DE69125216T patent/DE69125216T2/de not_active Expired - Fee Related
- 1991-07-18 EP EP91810580A patent/EP0467856B1/en not_active Expired - Lifetime
-
1993
- 1993-12-15 US US08/167,459 patent/US5430052A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5430052A (en) | 1995-07-04 |
EP0467856A3 (en) | 1992-10-14 |
DE69125216D1 (de) | 1997-04-24 |
ATE150301T1 (de) | 1997-04-15 |
DE69125216T2 (de) | 1997-09-25 |
EP0467856B1 (en) | 1997-03-19 |
EP0467856A2 (en) | 1992-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2100222T3 (es) | Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas. | |
PT723540E (pt) | Compostos triciclicos de amida e ureia uteis para inibicao da funcao da g-proteina e para o tratamento de doencas proliferativas. | |
OA09039A (fr) | Acides 3-alcenyl-1-azabicyclo(3.2.0)hep-2-ene-2carboxyliques | |
EP0371559A3 (en) | Use of benzimidazoles in the treatment of epithelial disorders | |
PT97395A (pt) | Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem | |
KR880009948A (ko) | 항 알레르기 및 항 염증제로서 용도를 갖는 신규의 나프탈렌 유도체 | |
KR940005274A (ko) | 쇼그렌(Sjoegren)증후군 치료제 | |
BR9807950A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto | |
DE4394931T1 (de) | Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen | |
FI102964B (fi) | Menetelmä terapeuttisesti käyttökelpoisen 4-substituoitu-1-(9,10-dihyd ro-9,10-metanoantrasen-9-yylimetyyli)piperidin-4-olijohdannaisen tuott amiseksi sekä menetelmän välituotteet | |
DE69029693D1 (de) | Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz | |
HUT66515A (en) | Process for preparing piperidine derivatives and pharmaceutical compositions contg. them as active ingredients | |
DK0570294T3 (da) | 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel | |
ES538847A0 (es) | Un derivado de fenilserina | |
ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
ES2053668T3 (es) | Derivados de poliamina como agentes antineoplasicos. | |
BR9910628A (pt) | Uso de um composto da série da benzofuroxana, composição farmacêutica, e, processos para a preparação de uma formulação parenteral e para o tratamento de um mamìfero, incluindo um ser humano, de doenças cardìacas da coronária | |
FR2549049B1 (fr) | Nouvelles amidines, leur procede de preparation et leur application therapeutique | |
ATE169217T1 (de) | Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten | |
PT92047A (pt) | Processo para a preparacao de derivados de nitroxialquilaminas com a funcao amida, de compostos intermediarios e de composicoes farmaceuticas que as contem | |
BR9813775A (pt) | Uso de um composto, processo para o tratamento de uma condição de cefaléia vascular, e, composição farmacêutica adequada para uso no tratamento de uma condição de cefaléia vascular. | |
DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
NZ216110A (en) | 4-(z)-6-((2,4,5-cis -2-alkyl-4-(2-hydroxyphenyl)-1,3- dioxan-5-yl) hexenoic acid derivatives and pharmaceutical compositions | |
KR900000383A (ko) | 신규 화합물 | |
BR0016329A (pt) | Bis-indolilmaleimidas substituìdas para inibição de proliferação de células |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 467856 Country of ref document: ES |